Novo Nordisk Stock Today (Nov 6, 2025): NVO steadies as White House GLP‑1 pricing deal lands; $10B Metsera bidding war heats up
Date: Thursday, November 6, 2025Ticker: NVO (NYSE) At a glance: price action and catalysts Novo Nordisk stock traded around $47.36 as of 17:52 UTC, after opening at $47.75 and moving between $46.91–$49.49 on heavy volume. The tape is being driven by two big headlines: (1) a White House pricing agreement that expands access to GLP‑1 drugs across Medicare/Medicaid and a new direct‑to‑consumer channel, and (2) a $10 billion bidding battle with Pfizer for obesity‑drug startup Metsera. What changed today 1) White House pricing deal lowers GLP‑1 costs and expands coverage The administration announced a deal with Novo Nordisk and Eli